VX15-809-110: A Phase 3, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor in Subjects Aged 6 Years and Older With Cystic Fibrosis, Homozygous for the F508de

Project: Research project

Project Details

StatusFinished
Effective start/end date10/1/151/18/19

Funding

  • Vertex Pharmaceuticals Incorporated
  • Vertex Pharmaceuticals Incorporated